Overview
The GMO Equity Dislocation Investment Fund seeks high total return. We aim to accomplish this objective by owning attractively valued equities while correspondingly shorting equities where we believe that valuations are reflective of implausible growth expectations. The eligible universe for both the long and short side spans the market capitalization spectrum and includes both developed and emerging markets. The portfolio is diversified across sectors, countries, and regions and is intended to be broadly dollar neutral with an approximate ex-ante beta of zero.
Facts
Performance
Documents
Literature
Fact Sheet | Download | |
Prospectus | Download | |
Prospectus - Fifth Supplement | Download | |
Prospectus - First Supplement | Download | |
Prospectus - Fourth Supplement | Download | |
Prospectus - Second Supplement | Download | |
Prospectus – Singapore Wrapper | Download | |
Prospectus - Sixth Supplement | Download | |
Prospectus - Third Supplement | Download | |
Prospectus - UK Supplement | Download | |
KIID - EUR | Download | |
KIID - GBP | Download | |
KIID - USD | Download | |
PRIIP - AUD | Download | |
PRIIP - EUR | Download | |
PRIIP - USD | Download | |
Download All | Download |
Downloads
Performance | Download | |
Portfolio Composition | Download | |
Holdings | Download | |
Download All | Download |
Commentary & Attribution
Risks
Risks associated with investing in the Fund may include Equities Risks, Short Investment Exposure Risks, Risks of Non-U.S. Investments, Preferred Securities Risk and Depositary Receipts Risk. For a more complete discussion of these risks and others, please consult the Fund's Prospectus
Disclosures
The making available of any document on this website does not constitute a promotion, offer or sale of any securities, financial instruments, or other financial products to the public in or into any jurisdiction where such promotion, offer or sale is prohibited or to any person or class of person to whom such securities or financial instruments may not be lawfully promoted, offered or sold. You should not rely on any document on this website in making any decision to engage in investment activity without seeking further information from GMO to enable GMO to determine whether you may be eligible to receive such further information or purchase or subscribe for any securities or other financial instruments.